2002
DOI: 10.1210/me.2002-0070
|View full text |Cite
|
Sign up to set email alerts
|

The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions

Abstract: The biological activity of testosterone and dihydrotestosterone is thought to occur predominantly through binding to the androgen receptor (AR), a member of the nuclear receptor superfamily that functions as a ligand-activated transcription factor. However, androgens have also been reported to induce the rapid activation of kinase-signaling cascades and modulate intracellular calcium levels. These effects are considered to be nongenomic because they occur in cell types that lack a functional AR, in the presenc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

9
306
0
10

Year Published

2004
2004
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 471 publications
(325 citation statements)
references
References 66 publications
9
306
0
10
Order By: Relevance
“…Most extensively, this activity (tentatively named R SHBG ) has been studied in the breast cancer cell line MCF7. In this cell type, SHBG has been implicated in cAMP-dependent signaling of bound-estradiol (Heinlein and Chang, 2002;Kahn et al, 2008;Nakhla et al, 1999;Rosner et al, 1999). Furthermore, the carrier has been shown to antagonize estradiol-induced proliferation of these cells by inhibiting the activation of extracellular regulated kinase (ERK) -1/-2 (Catalano et al, 2005) and by regulating expression of downstream target genes involved in cell growth and Page 7 of 44 A c c e p t e d M a n u s c r i p t 7 apoptosis (Catalano et al, 2007;Fortunati and Catalano, 2006).…”
Section: Receptors For Steroid Carriers -Surface Binding Sites For Stmentioning
confidence: 99%
“…Most extensively, this activity (tentatively named R SHBG ) has been studied in the breast cancer cell line MCF7. In this cell type, SHBG has been implicated in cAMP-dependent signaling of bound-estradiol (Heinlein and Chang, 2002;Kahn et al, 2008;Nakhla et al, 1999;Rosner et al, 1999). Furthermore, the carrier has been shown to antagonize estradiol-induced proliferation of these cells by inhibiting the activation of extracellular regulated kinase (ERK) -1/-2 (Catalano et al, 2005) and by regulating expression of downstream target genes involved in cell growth and Page 7 of 44 A c c e p t e d M a n u s c r i p t 7 apoptosis (Catalano et al, 2007;Fortunati and Catalano, 2006).…”
Section: Receptors For Steroid Carriers -Surface Binding Sites For Stmentioning
confidence: 99%
“…After ligand binding, heat-shock proteins dissociate from the receptor, and then the AR translocates to the nucleus [3], where it regulates transcription by binding to specific androgen response elements in promoters of target genes. Together with co-regulatory proteins and general transcription factors, a stable transcription initiation complex is formed [4][5][6]. An important feature of ligand binding is that it induces a conformational change in the AR LBD (ligand-binding domain), providing a surface for interactions with co-regulatory proteins.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, AR mediates nongenomic androgen effects, intracellular calcium flux and kinase activation. 3 In androgen-independent cell lines, AR may cause cell growth in the absence of ligand. 4 Unlawful AR activation can occur without steroids via surface receptors, like HER-2, 5 or by growth factors, like interleukin-6, oncostatin-M or bombesin.…”
mentioning
confidence: 99%